ResMed Inc (RMD) stock
RMDNYSESurgical & Medical Instruments & ApparatusFiscal year ends June 30Also trades as RSMDF
Financials through Q1 FY2027, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 30, 2026Score 21/3014% below fair value
$237.85−0.34 (-0.14%)
Close on Nov 17, 2026Market cap $33.46BP/E 21.7Yield 1.01%
ResMed price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
ResMed's price to book ratio was 5.2× on Nov 11, 2026, against 6.1× a year earlier. Over the last 5 years it ranged from 4.3× to 12.5×, with a median of 6.7×.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 5.2× | −0.5 |
| 2025 | Dec 31, 2025 | 5.7× | −0.7 |
| 2024 | Dec 31, 2024 | 6.5× | +0.5 |
| 2023 | Dec 29, 2023 | 6.0× | −2.9 |
| 2022 | Dec 30, 2022 | 8.9× | −3.7 |
| 2021 | Dec 31, 2021 | 12.5× | +1.0 |
| 2020 | Dec 31, 2020 | 11.5× | +1.0 |
| 2019 | Dec 31, 2019 | 10.5× | +2.0 |
| 2018 | Dec 31, 2018 | 8.5× | +2.7 |
| 2017 | Dec 29, 2017 | 5.9× | +0.9 |
| 2016 | Dec 30, 2016 | 4.9× | −0.2 |
| 2015 | Dec 31, 2015 | 5.1× | +0.4 |
| 2014 | Dec 31, 2014 | 4.7× | +0.2 |
| 2013 | Oct 31, 2013 | 4.6× | +1.0 |
| 2012 | Oct 31, 2012 | 3.5× | +1.0 |
| 2011 | Oct 31, 2011 | 2.5× | – |
See a number that looks wrong?